 | • レポートコード：MRC23Q36458 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の0.9%塩化ナトリウム注射市場について調査・分析し、世界の0.9%塩化ナトリウム注射市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（100ml、250ml、500ml、その他）、用途別セグメント分析（病院、診療所、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Sichuan Kelun Pharmaceutical Co.,Ltd.、Hangzhou Minsheng Pharmaceutical Co., Ltd.、Jiangsu Hengrui Pharmaceuticals Co.,ltd.、SSY Group Limited、Jiangsu Sihuan Bioengineering Co.,Ltd.、China Resources Double-crane Pharmaceutical Co.,Ltd.、Sichuan Biokin Pharmaceutical Co.,Ltd.、Anhui Fengyuan Pharmaceutical Co.,Ltd.、Cisen Pharmaceutical、Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.、Anhui Changjiang Pharmaceutical Co., Ltd.、PKU HealthCare Corp.,Ltd.、CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.、Hebei TIANCHENG Pharmaceutical Co., Ltd.、Southwest Pharmaceutical Co., Ltd.、Pfizer、Amphastar、AstraZeneca plc.、Fresenius Kabi、Baxter、Otsuka Pharmaceutical、Novartis、BBraun、Huaren Pharmaceutical Co.,Ltd.、Jilin Province Dubang Pharmaceuticals Co., Ltd.、Jiangsu Suzhong PHARMA Group Co., Ltd.、Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.、Shandong Weigao Pharmaceutical Co., Ltd.、Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.などが含まれています。 世界の0.9%塩化ナトリウム注射市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、0.9%塩化ナトリウム注射市場規模を推定する際に考慮しました。本レポートは、0.9%塩化ナトリウム注射の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、0.9%塩化ナトリウム注射に関するビジネス上の意思決定に役立てることを目的としています。 ・0.9%塩化ナトリウム注射市場の概要 - 製品の定義 - 0.9%塩化ナトリウム注射のタイプ別セグメント - 世界の0.9%塩化ナトリウム注射市場規模：タイプ別分析（100ml、250ml、500ml、その他） - 0.9%塩化ナトリウム注射の用途別セグメント - 世界の0.9%塩化ナトリウム注射市場規模：用途別分析（病院、診療所、その他） - 世界の0.9%塩化ナトリウム注射市場規模予測（2018年-2029年） - 0.9%塩化ナトリウム注射の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 0.9%塩化ナトリウム注射市場の競争状況およびトレンド ・0.9%塩化ナトリウム注射の地域別市場規模 - 北米の0.9%塩化ナトリウム注射市場規模（2018年-2029年） - アメリカの0.9%塩化ナトリウム注射市場規模（2018年-2029年） - ヨーロッパの0.9%塩化ナトリウム注射市場規模（2018年-2029年） - アジア太平洋の0.9%塩化ナトリウム注射市場規模（2018年-2029年） - 中国の0.9%塩化ナトリウム注射市場規模（2018年-2029年） - 日本の0.9%塩化ナトリウム注射市場規模（2018年-2029年） - 韓国の0.9%塩化ナトリウム注射市場規模（2018年-2029年） - インドの0.9%塩化ナトリウム注射市場規模（2018年-2029年） - オーストラリアの0.9%塩化ナトリウム注射市場規模（2018年-2029年） - 中南米の0.9%塩化ナトリウム注射市場規模（2018年-2029年） - 中東・アフリカの0.9%塩化ナトリウム注射市場規模（2018年-2029年） ・タイプ別セグメント：100ml、250ml、500ml、その他 - 世界の0.9%塩化ナトリウム注射のタイプ別販売量（2018年-2023年） - 世界の0.9%塩化ナトリウム注射のタイプ別売上（2018年-2023年） - 世界の0.9%塩化ナトリウム注射のタイプ別価格 ・用途別セグメント：病院、診療所、その他 - 世界の0.9%塩化ナトリウム注射の用途別販売量（2018年-2023年） - 世界の0.9%塩化ナトリウム注射の用途別売上（2018年-2023年） - 世界の0.9%塩化ナトリウム注射の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Sichuan Kelun Pharmaceutical Co.,Ltd.、Hangzhou Minsheng Pharmaceutical Co., Ltd.、Jiangsu Hengrui Pharmaceuticals Co.,ltd.、SSY Group Limited、Jiangsu Sihuan Bioengineering Co.,Ltd.、China Resources Double-crane Pharmaceutical Co.,Ltd.、Sichuan Biokin Pharmaceutical Co.,Ltd.、Anhui Fengyuan Pharmaceutical Co.,Ltd.、Cisen Pharmaceutical、Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.、Anhui Changjiang Pharmaceutical Co., Ltd.、PKU HealthCare Corp.,Ltd.、CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.、Hebei TIANCHENG Pharmaceutical Co., Ltd.、Southwest Pharmaceutical Co., Ltd.、Pfizer、Amphastar、AstraZeneca plc.、Fresenius Kabi、Baxter、Otsuka Pharmaceutical、Novartis、BBraun、Huaren Pharmaceutical Co.,Ltd.、Jilin Province Dubang Pharmaceuticals Co., Ltd.、Jiangsu Suzhong PHARMA Group Co., Ltd.、Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.、Shandong Weigao Pharmaceutical Co., Ltd.、Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. ・産業チェーンと販売チャネルの分析 - 0.9%塩化ナトリウム注射産業チェーン分析 - 0.9%塩化ナトリウム注射の主要原材料 - 0.9%塩化ナトリウム注射の販売チャネル - 0.9%塩化ナトリウム注射のディストリビューター - 0.9%塩化ナトリウム注射の主要顧客 ・0.9%塩化ナトリウム注射市場ダイナミクス - 0.9%塩化ナトリウム注射の業界動向 - 0.9%塩化ナトリウム注射市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Sodium chloride is an electrolyte supplement. Sodium and chlorine are important electrolytes in the body, which mainly exist in the extracellular fluid and play a very important role in maintaining the normal volume and osmotic pressure of blood and extracellular fluid. The concentration of normal serum Na+is 135~145mmol/L, accounting for 92% of plasma cation and 90% of total osmotic pressure. Therefore, the amount of plasma sodium plays a decisive role in osmotic pressure. The normal serum Cl – concentration is 98 ～ 106mmol/L. Sodium and chloride ions in human body are mainly regulated by hypothalamus, posterior pituitary and kidney to maintain the stability of body fluid volume and osmotic pressure. The injection concentration is usually 0.9%. This report studies the 0.9% concentration of sodium chloride injection.
Highlights
The global 0.9% Sodium Chloride Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for 0.9% Sodium Chloride Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for 0.9% Sodium Chloride Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of 0.9% Sodium Chloride Injection include Sichuan Kelun Pharmaceutical Co.,Ltd., Hangzhou Minsheng Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd., SSY Group Limited, Jiangsu Sihuan Bioengineering Co.,Ltd., China Resources Double-crane Pharmaceutical Co.,Ltd., Sichuan Biokin Pharmaceutical Co.,Ltd., Anhui Fengyuan Pharmaceutical Co.,Ltd. and Cisen Pharmaceutical, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for 0.9% Sodium Chloride Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 0.9% Sodium Chloride Injection.
The 0.9% Sodium Chloride Injection market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global 0.9% Sodium Chloride Injection market comprehensively. Regional market sizes, concerning products by specification, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 0.9% Sodium Chloride Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by specification, by application and by regions.
By Company
Sichuan Kelun Pharmaceutical Co.,Ltd.
Hangzhou Minsheng Pharmaceutical Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co.,ltd.
SSY Group Limited
Jiangsu Sihuan Bioengineering Co.,Ltd.
China Resources Double-crane Pharmaceutical Co.,Ltd.
Sichuan Biokin Pharmaceutical Co.,Ltd.
Anhui Fengyuan Pharmaceutical Co.,Ltd.
Cisen Pharmaceutical
Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.
Anhui Changjiang Pharmaceutical Co., Ltd.
PKU HealthCare Corp.,Ltd.
CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
Hebei TIANCHENG Pharmaceutical Co., Ltd.
Southwest Pharmaceutical Co., Ltd.
Pfizer
Amphastar
AstraZeneca plc.
Fresenius Kabi
Baxter
Otsuka Pharmaceutical
Novartis
BBraun
Huaren Pharmaceutical Co.,Ltd.
Jilin Province Dubang Pharmaceuticals Co., Ltd.
Jiangsu Suzhong PHARMA Group Co., Ltd.
Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
Shandong Weigao Pharmaceutical Co., Ltd.
Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
Segment by Specification
100ml
250ml
500ml
Other
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of 0.9% Sodium Chloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of 0.9% Sodium Chloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by specification, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 0.9% Sodium Chloride Injection Market Overview
1.1 Product Overview and Scope of 0.9% Sodium Chloride Injection
1.2 0.9% Sodium Chloride Injection Segment by Specification
1.2.1 Global 0.9% Sodium Chloride Injection Market Value Comparison by Specification (2023-2029)
1.2.2 100ml
1.2.3 250ml
1.2.4 500ml
1.2.5 Other
1.3 0.9% Sodium Chloride Injection Segment by Application
1.3.1 Global 0.9% Sodium Chloride Injection Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global 0.9% Sodium Chloride Injection Market Size Estimates and Forecasts
1.4.1 Global 0.9% Sodium Chloride Injection Revenue 2018-2029
1.4.2 Global 0.9% Sodium Chloride Injection Sales 2018-2029
1.4.3 Global 0.9% Sodium Chloride Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 0.9% Sodium Chloride Injection Market Competition by Manufacturers
2.1 Global 0.9% Sodium Chloride Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global 0.9% Sodium Chloride Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global 0.9% Sodium Chloride Injection Average Price by Manufacturers (2018-2023)
2.4 Global 0.9% Sodium Chloride Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of 0.9% Sodium Chloride Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of 0.9% Sodium Chloride Injection, Product Type & Application
2.7 0.9% Sodium Chloride Injection Market Competitive Situation and Trends
2.7.1 0.9% Sodium Chloride Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest 0.9% Sodium Chloride Injection Players Market Share by Revenue
2.7.3 Global 0.9% Sodium Chloride Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 0.9% Sodium Chloride Injection Retrospective Market Scenario by Region
3.1 Global 0.9% Sodium Chloride Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global 0.9% Sodium Chloride Injection Global 0.9% Sodium Chloride Injection Sales by Region: 2018-2029
3.2.1 Global 0.9% Sodium Chloride Injection Sales by Region: 2018-2023
3.2.2 Global 0.9% Sodium Chloride Injection Sales by Region: 2024-2029
3.3 Global 0.9% Sodium Chloride Injection Global 0.9% Sodium Chloride Injection Revenue by Region: 2018-2029
3.3.1 Global 0.9% Sodium Chloride Injection Revenue by Region: 2018-2023
3.3.2 Global 0.9% Sodium Chloride Injection Revenue by Region: 2024-2029
3.4 North America 0.9% Sodium Chloride Injection Market Facts & Figures by Country
3.4.1 North America 0.9% Sodium Chloride Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America 0.9% Sodium Chloride Injection Sales by Country (2018-2029)
3.4.3 North America 0.9% Sodium Chloride Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe 0.9% Sodium Chloride Injection Market Facts & Figures by Country
3.5.1 Europe 0.9% Sodium Chloride Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe 0.9% Sodium Chloride Injection Sales by Country (2018-2029)
3.5.3 Europe 0.9% Sodium Chloride Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 0.9% Sodium Chloride Injection Market Facts & Figures by Country
3.6.1 Asia Pacific 0.9% Sodium Chloride Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific 0.9% Sodium Chloride Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific 0.9% Sodium Chloride Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America 0.9% Sodium Chloride Injection Market Facts & Figures by Country
3.7.1 Latin America 0.9% Sodium Chloride Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America 0.9% Sodium Chloride Injection Sales by Country (2018-2029)
3.7.3 Latin America 0.9% Sodium Chloride Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa 0.9% Sodium Chloride Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa 0.9% Sodium Chloride Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa 0.9% Sodium Chloride Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa 0.9% Sodium Chloride Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Specification
4.1 Global 0.9% Sodium Chloride Injection Sales by Specification (2018-2029)
4.1.1 Global 0.9% Sodium Chloride Injection Sales by Specification (2018-2023)
4.1.2 Global 0.9% Sodium Chloride Injection Sales by Specification (2024-2029)
4.1.3 Global 0.9% Sodium Chloride Injection Sales Market Share by Specification (2018-2029)
4.2 Global 0.9% Sodium Chloride Injection Revenue by Specification (2018-2029)
4.2.1 Global 0.9% Sodium Chloride Injection Revenue by Specification (2018-2023)
4.2.2 Global 0.9% Sodium Chloride Injection Revenue by Specification (2024-2029)
4.2.3 Global 0.9% Sodium Chloride Injection Revenue Market Share by Specification (2018-2029)
4.3 Global 0.9% Sodium Chloride Injection Price by Specification (2018-2029)
5 Segment by Application
5.1 Global 0.9% Sodium Chloride Injection Sales by Application (2018-2029)
5.1.1 Global 0.9% Sodium Chloride Injection Sales by Application (2018-2023)
5.1.2 Global 0.9% Sodium Chloride Injection Sales by Application (2024-2029)
5.1.3 Global 0.9% Sodium Chloride Injection Sales Market Share by Application (2018-2029)
5.2 Global 0.9% Sodium Chloride Injection Revenue by Application (2018-2029)
5.2.1 Global 0.9% Sodium Chloride Injection Revenue by Application (2018-2023)
5.2.2 Global 0.9% Sodium Chloride Injection Revenue by Application (2024-2029)
5.2.3 Global 0.9% Sodium Chloride Injection Revenue Market Share by Application (2018-2029)
5.3 Global 0.9% Sodium Chloride Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sichuan Kelun Pharmaceutical Co.,Ltd.
6.1.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Corporation Information
6.1.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Description and Business Overview
6.1.3 Sichuan Kelun Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sichuan Kelun Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
6.1.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.2 Hangzhou Minsheng Pharmaceutical Co., Ltd.
6.2.1 Hangzhou Minsheng Pharmaceutical Co., Ltd. Corporation Information
6.2.2 Hangzhou Minsheng Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Hangzhou Minsheng Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Hangzhou Minsheng Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
6.2.5 Hangzhou Minsheng Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
6.3.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Corporation Information
6.3.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Description and Business Overview
6.3.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. 0.9% Sodium Chloride Injection Product Portfolio
6.3.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments/Updates
6.4 SSY Group Limited
6.4.1 SSY Group Limited Corporation Information
6.4.2 SSY Group Limited Description and Business Overview
6.4.3 SSY Group Limited 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 SSY Group Limited 0.9% Sodium Chloride Injection Product Portfolio
6.4.5 SSY Group Limited Recent Developments/Updates
6.5 Jiangsu Sihuan Bioengineering Co.,Ltd.
6.5.1 Jiangsu Sihuan Bioengineering Co.,Ltd. Corporation Information
6.5.2 Jiangsu Sihuan Bioengineering Co.,Ltd. Description and Business Overview
6.5.3 Jiangsu Sihuan Bioengineering Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Jiangsu Sihuan Bioengineering Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
6.5.5 Jiangsu Sihuan Bioengineering Co.,Ltd. Recent Developments/Updates
6.6 China Resources Double-crane Pharmaceutical Co.,Ltd.
6.6.1 China Resources Double-crane Pharmaceutical Co.,Ltd. Corporation Information
6.6.2 China Resources Double-crane Pharmaceutical Co.,Ltd. Description and Business Overview
6.6.3 China Resources Double-crane Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 China Resources Double-crane Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
6.6.5 China Resources Double-crane Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.7 Sichuan Biokin Pharmaceutical Co.,Ltd.
6.6.1 Sichuan Biokin Pharmaceutical Co.,Ltd. Corporation Information
6.6.2 Sichuan Biokin Pharmaceutical Co.,Ltd. Description and Business Overview
6.6.3 Sichuan Biokin Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sichuan Biokin Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
6.7.5 Sichuan Biokin Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.8 Anhui Fengyuan Pharmaceutical Co.,Ltd.
6.8.1 Anhui Fengyuan Pharmaceutical Co.,Ltd. Corporation Information
6.8.2 Anhui Fengyuan Pharmaceutical Co.,Ltd. Description and Business Overview
6.8.3 Anhui Fengyuan Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Anhui Fengyuan Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
6.8.5 Anhui Fengyuan Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.9 Cisen Pharmaceutical
6.9.1 Cisen Pharmaceutical Corporation Information
6.9.2 Cisen Pharmaceutical Description and Business Overview
6.9.3 Cisen Pharmaceutical 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cisen Pharmaceutical 0.9% Sodium Chloride Injection Product Portfolio
6.9.5 Cisen Pharmaceutical Recent Developments/Updates
6.10 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.
6.10.1 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. Corporation Information
6.10.2 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. Description and Business Overview
6.10.3 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. 0.9% Sodium Chloride Injection Product Portfolio
6.10.5 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. Recent Developments/Updates
6.11 Anhui Changjiang Pharmaceutical Co., Ltd.
6.11.1 Anhui Changjiang Pharmaceutical Co., Ltd. Corporation Information
6.11.2 Anhui Changjiang Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Description and Business Overview
6.11.3 Anhui Changjiang Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Anhui Changjiang Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
6.11.5 Anhui Changjiang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 PKU HealthCare Corp.,Ltd.
6.12.1 PKU HealthCare Corp.,Ltd. Corporation Information
6.12.2 PKU HealthCare Corp.,Ltd. 0.9% Sodium Chloride Injection Description and Business Overview
6.12.3 PKU HealthCare Corp.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 PKU HealthCare Corp.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
6.12.5 PKU HealthCare Corp.,Ltd. Recent Developments/Updates
6.13 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
6.13.1 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. Corporation Information
6.13.2 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. 0.9% Sodium Chloride Injection Description and Business Overview
6.13.3 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. 0.9% Sodium Chloride Injection Product Portfolio
6.13.5 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. Recent Developments/Updates
6.14 Hebei TIANCHENG Pharmaceutical Co., Ltd.
6.14.1 Hebei TIANCHENG Pharmaceutical Co., Ltd. Corporation Information
6.14.2 Hebei TIANCHENG Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Description and Business Overview
6.14.3 Hebei TIANCHENG Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Hebei TIANCHENG Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
6.14.5 Hebei TIANCHENG Pharmaceutical Co., Ltd. Recent Developments/Updates
6.15 Southwest Pharmaceutical Co., Ltd.
6.15.1 Southwest Pharmaceutical Co., Ltd. Corporation Information
6.15.2 Southwest Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Description and Business Overview
6.15.3 Southwest Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Southwest Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
6.15.5 Southwest Pharmaceutical Co., Ltd. Recent Developments/Updates
6.16 Pfizer
6.16.1 Pfizer Corporation Information
6.16.2 Pfizer 0.9% Sodium Chloride Injection Description and Business Overview
6.16.3 Pfizer 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Pfizer 0.9% Sodium Chloride Injection Product Portfolio
6.16.5 Pfizer Recent Developments/Updates
6.17 Amphastar
6.17.1 Amphastar Corporation Information
6.17.2 Amphastar 0.9% Sodium Chloride Injection Description and Business Overview
6.17.3 Amphastar 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Amphastar 0.9% Sodium Chloride Injection Product Portfolio
6.17.5 Amphastar Recent Developments/Updates
6.18 AstraZeneca plc.
6.18.1 AstraZeneca plc. Corporation Information
6.18.2 AstraZeneca plc. 0.9% Sodium Chloride Injection Description and Business Overview
6.18.3 AstraZeneca plc. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.18.4 AstraZeneca plc. 0.9% Sodium Chloride Injection Product Portfolio
6.18.5 AstraZeneca plc. Recent Developments/Updates
6.19 Fresenius Kabi
6.19.1 Fresenius Kabi Corporation Information
6.19.2 Fresenius Kabi 0.9% Sodium Chloride Injection Description and Business Overview
6.19.3 Fresenius Kabi 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Fresenius Kabi 0.9% Sodium Chloride Injection Product Portfolio
6.19.5 Fresenius Kabi Recent Developments/Updates
6.20 Baxter
6.20.1 Baxter Corporation Information
6.20.2 Baxter 0.9% Sodium Chloride Injection Description and Business Overview
6.20.3 Baxter 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Baxter 0.9% Sodium Chloride Injection Product Portfolio
6.20.5 Baxter Recent Developments/Updates
6.21 Otsuka Pharmaceutical
6.21.1 Otsuka Pharmaceutical Corporation Information
6.21.2 Otsuka Pharmaceutical 0.9% Sodium Chloride Injection Description and Business Overview
6.21.3 Otsuka Pharmaceutical 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Otsuka Pharmaceutical 0.9% Sodium Chloride Injection Product Portfolio
6.21.5 Otsuka Pharmaceutical Recent Developments/Updates
6.22 Novartis
6.22.1 Novartis Corporation Information
6.22.2 Novartis 0.9% Sodium Chloride Injection Description and Business Overview
6.22.3 Novartis 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Novartis 0.9% Sodium Chloride Injection Product Portfolio
6.22.5 Novartis Recent Developments/Updates
6.23 BBraun
6.23.1 BBraun Corporation Information
6.23.2 BBraun 0.9% Sodium Chloride Injection Description and Business Overview
6.23.3 BBraun 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.23.4 BBraun 0.9% Sodium Chloride Injection Product Portfolio
6.23.5 BBraun Recent Developments/Updates
6.24 Huaren Pharmaceutical Co.,Ltd.
6.24.1 Huaren Pharmaceutical Co.,Ltd. Corporation Information
6.24.2 Huaren Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Description and Business Overview
6.24.3 Huaren Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Huaren Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
6.24.5 Huaren Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.25 Jilin Province Dubang Pharmaceuticals Co., Ltd.
6.25.1 Jilin Province Dubang Pharmaceuticals Co., Ltd. Corporation Information
6.25.2 Jilin Province Dubang Pharmaceuticals Co., Ltd. 0.9% Sodium Chloride Injection Description and Business Overview
6.25.3 Jilin Province Dubang Pharmaceuticals Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.25.4 Jilin Province Dubang Pharmaceuticals Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
6.25.5 Jilin Province Dubang Pharmaceuticals Co., Ltd. Recent Developments/Updates
6.26 Jiangsu Suzhong PHARMA Group Co., Ltd.
6.26.1 Jiangsu Suzhong PHARMA Group Co., Ltd. Corporation Information
6.26.2 Jiangsu Suzhong PHARMA Group Co., Ltd. 0.9% Sodium Chloride Injection Description and Business Overview
6.26.3 Jiangsu Suzhong PHARMA Group Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.26.4 Jiangsu Suzhong PHARMA Group Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
6.26.5 Jiangsu Suzhong PHARMA Group Co., Ltd. Recent Developments/Updates
6.27 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
6.27.1 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Corporation Information
6.27.2 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Description and Business Overview
6.27.3 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.27.4 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
6.27.5 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Recent Developments/Updates
6.28 Shandong Weigao Pharmaceutical Co., Ltd.
6.28.1 Shandong Weigao Pharmaceutical Co., Ltd. Corporation Information
6.28.2 Shandong Weigao Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Description and Business Overview
6.28.3 Shandong Weigao Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.28.4 Shandong Weigao Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
6.28.5 Shandong Weigao Pharmaceutical Co., Ltd. Recent Developments/Updates
6.29 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
6.29.1 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Corporation Information
6.29.2 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. 0.9% Sodium Chloride Injection Description and Business Overview
6.29.3 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.29.4 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
6.29.5 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 0.9% Sodium Chloride Injection Industry Chain Analysis
7.2 0.9% Sodium Chloride Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 0.9% Sodium Chloride Injection Production Mode & Process
7.4 0.9% Sodium Chloride Injection Sales and Marketing
7.4.1 0.9% Sodium Chloride Injection Sales Channels
7.4.2 0.9% Sodium Chloride Injection Distributors
7.5 0.9% Sodium Chloride Injection Customers
8 0.9% Sodium Chloride Injection Market Dynamics
8.1 0.9% Sodium Chloride Injection Industry Trends
8.2 0.9% Sodium Chloride Injection Market Drivers
8.3 0.9% Sodium Chloride Injection Market Challenges
8.4 0.9% Sodium Chloride Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer